Products
Online Inquiry
SRT3025 HCl
Cat. No.:
OB0225WX-2756
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
SRT3025 acts as an orally active small molecule designed to activate the SIRT1 enzyme.
Synonym:
2070015-26-6; SRT3025 Hydrochloride; Sirtuin modulator 1; 5-(3-methoxypropyl)-2-phenyl-N-(2-(6-(pyrrolidin-1-ylmethyl)thiazolo[5,4-b]pyridin-2-yl)phenyl)thiazole-4-carboxamide hydrochloride; 5-(3-methoxypropyl)-2-phenyl-N-[2-[6-(pyrrolidin-1-ylmethyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]-1,3-thiazole-4-carboxamide;hydrochloride; 5-(3-methoxypropyl)-2-phenyl-N-{2-[6-(pyrrolidin-1-ylmethyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl}-1,3-thiazole-4-carboxamide hydrochloride
CAS No.:
2070015-26-6
Compound CID:
118986647
Formula:
C31H31N5O2S2·HCl
Formula Weight:
606.2
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
SRT3025 HCl is used in metabolic and cardiovascular research as a potent SIRT1 activator to investigate the improvement of lipid profiles and the reduction of atherosclerotic plaque progression.
Library Information
Target:
Sirtuin
Receptor:
SIRT1
Pathways:
DNA damage/DNA repair
Plate Number:
L6700-10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
100 mg/mL; 164.96 mM
Ethanol Max Solubility:
5 mg/mL
ALogP:
5.849
HBA_Count:
5
HBD_Count:
1
Rotatable Bond:
10
